Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) (PALISADE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02635776
Recruitment Status : Completed
First Posted : December 21, 2015
Last Update Posted : July 16, 2018
Information provided by (Responsible Party):
Aimmune Therapeutics, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 21, 2017
  Actual Study Completion Date : July 2, 2018